The Indian Institute of Technology (IIT) Delhi and Wells Fargo have signed a memorandum of understanding (MoU) for development of a peptide-based ELISA test for the detection of Covid-19 antibodies.
ELISA, short for serological enzyme-linked immunosorbent assay, determines whether or not a person possesses antibodies for Covid-19 in the blood. The test results can help the medical fraternity fight the disease in many ways; a significant way would be the identification of individuals with antibodies who can donate their blood as part of an experimental treatment of infected patients.
Wells Fargo International Solutions Private Limited through their philanthropic partner, United Way of